Charleston, SC -- (SBWIRE) -- 09/16/2013 -- ImpressivePennyStocks.com covers several stocks on the NASDAQ and New York Stock Exchange that technically qualify as penny stocks, we typically find ones that are on the OTC Market. ImpressivePennyStocks.com issues a special report on the following stocks: Sunedison Inc (NYSE:SUNE), Galena Biopharma Inc (NASDAQ:GALE), Sprint Corporation (NYSE:S), Avanir Pharmaceuticals Inc (NASDAQ:AVNR).
Sunedison Inc (NYSE:SUNE) opened its last trade at the price of $7.46. Its closing price was $7.38 after losing -1.73% for the day. The company traded with the total volume of 26.29 million shares, while its average trading volume remained 7.30 million shares. The beta of this stock stands at 1.89. SunEdison, Inc. develops, manufactures, and sells silicon wafers. The company is also involved in developing and selling photovoltaic energy solutions. It operates in two segments, Semiconductor Materials and Solar Energy.
Has SUNE Found The Bottom and Ready To Move Up? Find Out Here
Galena Biopharma Inc (NASDAQ:GALE) percentage change plunged -14.91% to close at $1.94 with the total traded volume of 20.74 million shares, along with average volume of 2.22 million. The 52 week range of the stock remained $1.23 - $3.00, while its day lowest price was $1.85. The share price hit the day highest price of $1.95. Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide.
Has GALE Found The Bottom And Ready To Gain Momentum? Find Out Here
Sprint Corporation (NYSE:S) traded on volume of 17.34 million shares in the last session against average volume of 17.72 million shares. The company started its trading session with the price of $6.70 and closed at $6.72 by scoring +0.45%. Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands. It operates in two segments, Wireless and Wireline.
Will S Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) started its last trading session with the price of $- 18.24 and closed at $4.08 by scoring -18.24%. The stock traded with total volume of 15.10 million shares, while the average trading volume remained 3.82 million shares. The beta value of this stock stands at 1.82. Day range for the stock was $3.98 -$4.80. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
About Impressive Penny Stocks:
We are different here at Impressive Penny Stocks because we care about our subscribers. You can email us any time with questions, tips, or just to say hello. We are real people and we love to hear from our loyal subscribers.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the ImpressivePennyStocks.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
ImpressivePennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. ImpressivePennyStocks’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by ImpressivePennyStocks or an offer or solicitation to buy or sell any security. Neither the owner of ImpressivePennyStocks nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. ImpressivePennyStocks makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.
Read Full Disclaimer at: http://impressivepennystocks.com/disclaimer/#navigation
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)